277 related articles for article (PubMed ID: 33675650)
21. Pembrolizumab-induced cyclic ACTH-dependent Cushing's syndrome treated by a block-and-replace approach with osilodrostat.
Paepegaey AC; Dot JM; Beauvy J; Juttet P; Le Berre JP
Ann Endocrinol (Paris); 2022 Feb; 83(1):73-75. PubMed ID: 34871599
[No Abstract] [Full Text] [Related]
22. Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy.
Beauregard C; Dickstein G; Lacroix A
Treat Endocrinol; 2002; 1(2):79-94. PubMed ID: 15765624
[TBL] [Abstract][Full Text] [Related]
23. A multicenter, phase 2 study to evaluate the efficacy and safety of osilodrostat, a new 11β-hydroxylase inhibitor, in Japanese patients with endogenous Cushing's syndrome other than Cushing's disease.
Tanaka T; Satoh F; Ujihara M; Midorikawa S; Kaneko T; Takeda T; Suzuki A; Sato M; Shimatsu A
Endocr J; 2020 Aug; 67(8):841-852. PubMed ID: 32378529
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacological treatment in adrenal Cushing's syndrome.].
Stigliano A; Cerquetti L; Toscano V
Recenti Prog Med; 2016 Nov; 107(11):574-581. PubMed ID: 27869874
[TBL] [Abstract][Full Text] [Related]
25. Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole.
Corcuff JB; Young J; Masquefa-Giraud P; Chanson P; Baudin E; Tabarin A
Eur J Endocrinol; 2015 Apr; 172(4):473-81. PubMed ID: 25624013
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological Treatment of Cushing's Syndrome.
Castinetti F
Arch Med Res; 2023 Dec; 54(8):102908. PubMed ID: 37977919
[TBL] [Abstract][Full Text] [Related]
27. A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome.
Valassi E; Crespo I; Gich I; Rodríguez J; Webb SM
Clin Endocrinol (Oxf); 2012 Nov; 77(5):735-42. PubMed ID: 22533782
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological therapy of Cushing's syndrome: drugs and indications.
Díez JJ; Iglesias P
Mini Rev Med Chem; 2007 May; 7(5):467-80. PubMed ID: 17504182
[TBL] [Abstract][Full Text] [Related]
29. Use of ketoconazole in the treatment of Cushing's disease and ectopic ACTH syndrome.
Tabarin A; Navarranne A; Guérin J; Corcuff JB; Parneix M; Roger P
Clin Endocrinol (Oxf); 1991 Jan; 34(1):63-9. PubMed ID: 2004474
[TBL] [Abstract][Full Text] [Related]
30. Management of diabetes mellitus in Cushing's syndrome.
Munir A; Newell-Price J
Neuroendocrinology; 2010; 92 Suppl 1():82-5. PubMed ID: 20829624
[TBL] [Abstract][Full Text] [Related]
31. Evaluation and treatment of Cushing's syndrome.
Nieman LK; Ilias I
Am J Med; 2005 Dec; 118(12):1340-6. PubMed ID: 16378774
[TBL] [Abstract][Full Text] [Related]
32. [Medical treatment for Cushing's syndrome].
Nishikawa T; Saito J; Omura M
Nihon Rinsho; 2008 Jan; 66(1):186-91. PubMed ID: 18186263
[TBL] [Abstract][Full Text] [Related]
33. Adrenally Directed Medical Therapies for Cushing Syndrome.
Tritos NA
J Clin Endocrinol Metab; 2021 Jan; 106(1):16-25. PubMed ID: 33118025
[TBL] [Abstract][Full Text] [Related]
34. Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing's disease.
van den Bosch OF; Stades AM; Zelissen PM
Clin Endocrinol (Oxf); 2014 Feb; 80(2):184-90. PubMed ID: 23841642
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous adrenocorticotropic hormone (ACTH) normalisation due to tumour regression induced by metyrapone in a patient with ectopic ACTH syndrome: case report and literature review.
Iwayama H; Hirase S; Nomura Y; Ito T; Morita H; Otake K; Okumura A; Takagi J
BMC Endocr Disord; 2018 Mar; 18(1):19. PubMed ID: 29587720
[TBL] [Abstract][Full Text] [Related]
36. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
Findling JW; Kehoe ME; Shaker JL; Raff H
J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
[TBL] [Abstract][Full Text] [Related]
37. An evaluation of pharmacological options for Cushing's disease: what are the state-of-the-art options?
Martino M; Aboud N; Lucchetti B; Salvio G; Arnaldi G
Expert Opin Pharmacother; 2023 Apr; 24(5):557-576. PubMed ID: 36927238
[TBL] [Abstract][Full Text] [Related]
38. Cushing's disease: role of preoperative and primary medical therapy.
Castinetti F
Pituitary; 2022 Oct; 25(5):737-739. PubMed ID: 35780261
[TBL] [Abstract][Full Text] [Related]
39. Prolonged remission after long-term treatment with steroidogenesis inhibitors in Cushing's syndrome caused by ectopic ACTH secretion.
Sharma ST; Nieman LK
Eur J Endocrinol; 2012 Mar; 166(3):531-6. PubMed ID: 22190002
[TBL] [Abstract][Full Text] [Related]
40. Should we avoid using ketoconazole in patients with severe Cushing’s syndrome and increased levels of liver enzymes?
Ollivier M; Haissaguerre M; Ferriere A; Tabarin A
Eur J Endocrinol; 2018 Oct; 179(5):L1-L2. PubMed ID: 30320504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
